Molecular Chemical Imaging in Spontaneous Canine Cancer

Trial ended March 2022.

Patient Disease:

Multiple Tumor Types

Study Name:

Molecular Chemical Imaging in Spontaneous Canine Cancer

Purpose of the study:

  • To investigate the ability of a new technology to discriminate between tumor tissue and normal surrounding tissue during surgery

Primary Eligibility Criteria:

  • Dogs with a confirmed diagnosis of lung, kidney, or colorectal cancer
  • Tumor must be at least 10 mm in diameter
  • Owners must be planning for dog to have surgery to remove tumor
  • Adequate organ function to safely undergo general anesthesia, including a 30-minute extension to planned anesthesia duration for tumor removal
  • Must have received no prior treatment for tumor
  • Pets must come to CSU for all visits related to the clinical trial

Study Protocol:

  • In this study, pictures of the tumor and the surrounding tissues will be taken with a special camera during surgery; no chemicals or radiation are used to create the image
  • The pictures will be analyzed by computer algorithms to discriminate tumor versus normal tissues, which will be done after surgery
  • These results will not be available to surgeons at the time of the surgery and therefore the dog’s treatment will not be influenced by the results of these pictures

Owner Responsibilities:

  • Follow appointment schedule required by study protocol

Financial Incentives:

  • Study pays for the cost of histopathology ($121), and owners are given a $750 credit to their account at the VTH to be put towards the costs of surgery

If you have further questions about any of our clinical trials, please submit an online consult form. Your consult will then be directed to our trials team. Requests are typically returned within 5 business days.

flint animal cancer center newsletter

join our community

Be among the first to learn the latest Flint Animal Cancer Center news and pet cancer treatment information.
  • This field is for validation purposes and should be left unchanged.